# UVA-Riboflavin Crosslinking Treatment of Corneal Ectasia

> **NCT01325298** · PHASE2 · UNKNOWN · sponsor: **Mercy Center for Corrective Eye Surgery** · enrollment: 250 (estimated)

## Conditions studied

- Keratoconus
- Ectasia
- Corneal Ectasia

## Interventions

- **DEVICE:** UV-X Light
- **DRUG:** Riboflavin
- **DEVICE:** UV-X Light
- **DRUG:** Riboflavin

## Key facts

- **NCT ID:** NCT01325298
- **Lead sponsor:** Mercy Center for Corrective Eye Surgery
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-03
- **Primary completion:** 2014-03
- **Final completion:** 2014-05
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2011-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01325298

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01325298, "UVA-Riboflavin Crosslinking Treatment of Corneal Ectasia". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01325298. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*